CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 45 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-25 | Francis Chris | Exercise or conversion | +10,543 | $2.48 | $26K | 32,620 |
| 2018-09-25 | Francis Chris | Sale | −10,543 | $56.00 | $590K | 22,077 |
| 2018-09-25 | Francis Chris | Exercise or conversion · Share Option (right to buy) | −10,543 | 40,997 | ||
| 2018-09-24 | Francis Chris | Exercise or conversion | +1,032 | $2.48 | $3K | 23,109 |
| 2018-09-24 | Francis Chris | Sale | −1,032 | $56.00 | $58K | 22,077 |
| 2018-09-24 | Francis Chris | Exercise or conversion · Share Option (right to buy) | −1,032 | 51,540 | ||
| 2018-09-24 | Regnante Keith Chief Financial Officer | Exercise or conversion | +29,500 | $20.89 | $616K | 46,484 |
| 2018-09-24 | Regnante Keith Chief Financial Officer | Sale | −29,500 | $55.00 | $1.6M | 16,984 |
| 2018-09-24 | Regnante Keith Chief Financial Officer | Exercise or conversion · Share Option (right to buy) | −29,500 | 90,500 | ||
| 2018-09-24 | Vargeese Chandra Senior VP, Drug Discovery | Exercise or conversion | +3,000 | $2.48 | $7K | 30,300 |
| 2018-09-24 | Vargeese Chandra Senior VP, Drug Discovery | Sale | −3,000 | $55.00 | $165K | 27,300 |
| 2018-09-24 | Vargeese Chandra Senior VP, Drug Discovery | Exercise or conversion · Share Option (right to buy) | −3,000 | 149,542 | ||
| 2018-08-13 | Kolchinsky Peter Director | Grant or award · Share Option (right to buy) | +9,000 | 9,000 | ||
| 2018-08-13 | HENRY CHRISTIAN O Director | Grant or award · Share Option (right to buy) | +9,000 | 9,000 | ||
| 2018-08-13 | Verdine Gregory L. Director | Grant or award · Share Option (right to buy) | +9,000 | 9,000 | ||
| 2018-08-13 | TAKANASHI KEN Director | Grant or award · Share Option (right to buy) | +9,000 | 9,000 | ||
| 2018-08-13 | Miura Koji Director | Grant or award · Share Option (right to buy) | +9,000 | 9,000 | ||
| 2018-08-13 | Rawcliffe Adrian Director | Grant or award · Share Option (right to buy) | +9,000 | 9,000 | ||
| 2018-07-09 | Francis Chris | Exercise or conversion | +23,900 | $2.48 | $59K | 45,977 |
| 2018-07-09 | Francis Chris | Sale | −23,900 | $37.25 | $890K | 22,077 |
Page 20 of 22 · 433 trades